Vés al contingut

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group StudyComparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration ofFremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine inPediatric Patients 6 to 17 Years of Age

Obert
  • Codi protocol: TV48125-CNS-30082
  • Codi EudraCT: 2019-002058-33
  • Grup de recerca: Cefalea i dolor neurològic
  • Servei: Neurologia
  • Investigador/a principal:  Pozo Rosich, Patricia
  • Malaltia: Malalties del sistema nerviós
  • Fase: Fase III
  • Estat reclutament: Reclutant voluntaris